Inherited and acquired disorders of myelin: The underlying myelin pathology
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Remyelination is a major therapeutic goal in human myelin disorders, serving to restore function to demyelinated axons and providing neuroprotection. The target disorders that might be amenable to the promotion of this repair process are diverse and increasing in number. They range primarily from those of genetic, inflammatory to toxic origin. In order to apply remyelinating strategies to these disorders, it is essential to know whether the myelin damage results from a primary attack on myelin or the oligodendrocyte or both, and whether indeed these lead to myelin breakdown and demyelination. In some disorders, myelin sheath abnormalities are prominent but demyelination does not occur. This review explores the range of human and animal disorders where myelin pathology exists and focusses on defining the myelin changes in each and their cause, to help define whether they are targets for myelin repair therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
Lennon, V. A., Wingerchuk, D. M., Kryzer, T. J., Pittock, S. J., Lucchinetti, C. F., Fujihara, K., Nakashima, I., & Weinshenker, B. G. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17551-x · Cited by 3,239 · cited 6×
“The potential viral involvement in the etiology of MS has led to considerable interest in viruses that cause demyelination as models to explore the pathophysiology of MS.”
InfluentialIgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
Lennon, V. A., Kryzer, T. J., Pittock, S. J., Verkman, A. S., & Hinson, S. R. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050304 · Cited by 2,288 · cited 1×
“…autoantibody in NMO patients, resulted in its nosologic separation from MS. Lennon et al. (2004) first described the finding of an antibody AC C EP TE D M AN U SC R IP T (NMO-IgG) in NMO patients that was later determined to target the astrocytic water channel aquaporin-4 (Lennon et al., 2005).”
Multiple Sclerosis: An Immune or Neurodegenerative Disorder?
Trapp, B. D., & Nave, K.-A. (2008) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.30.051606.094313 · Cited by 1,724 · cited 1×
“…on OL death and inflammation and which comes first, the basic tenant that MS is an autoimmune, inflammatory disease of the CNS has been challenged and an alternative hypothesis is that it may be a neurodegenerative disorder with secondary inflammation (Stys et al., 2012; Trapp and Nave, 2008).”
Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity
Fünfschilling, U., Supplie, L. M., Mahad, D., Boretius, S., Saab, A. S., Edgar, J., Brinkmann, B. G., Kassmann, C. M., Tzvetanova, I. D., Möbius, W., et al. (2012) · Nature · doi:10.1038/nature11007 · Cited by 1,523 · cited 1×
“Interestingly, conditional knockout of the Cox10 gene leading to failure of assembly of stable mitochondrial cytochrome c oxidase, resulting in peripheral neuropathy but no CNS WM changes (Funfschilling et al., 2012).”
The Immunopathology of Multiple Sclerosis: An Overview
Lassmann, H., Brück, W., & Lucchinetti, C. F. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00064.x · Cited by 1,182
Myelination and support of axonal integrity by glia
Nave, K.-A. (2010) · Nature · doi:10.1038/nature09614 · Cited by 1,062
Gold, R. (2006) · Brain · doi:10.1093/brain/awl075 · Cited by 1,017 · cited 1×
“Despite the differences it has been extremely useful in helping dissect the immunopathology of MS and in the pursuit of MS therapies, and if utilized appropriately, EAE remains the closest model to MS (Denic et al., 2011; Gold et al., 2006; Ransohoff, 2012; Steinman and Zamvil, 2006).”
Matsushima, G. K., & Morell, P. (2001) · Brain Pathology · doi:10.1111/j.1750-3639.2001.tb00385.x · Cited by 984
Oligodendrocytes: biology and pathology
Bradl, M., & Lassmann, H. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0601-5 · Cited by 933 · cited 1×
“The origin of the OLs in the brain and spinal cord and their differentiation have been the subject of intense research and publication and have been reviewed in detail in this issue and elsewhere (Bradl and Lassmann, 2010; Richardson et al., 2006).”
Distinct Patterns of Multiple Sclerosis Pathology Indicates Heterogeneity in Pathogenesis
Lucchinetti, C. F., Brück, W., Rodriguez, M., & Lassmann, H. (1996) · Brain Pathology · doi:10.1111/j.1750-3639.1996.tb00854.x · Cited by 733
Cited by
Oligodendrocytes in development, myelin generation and beyond
Kuhn, S., Gritti, L., Crooks, D., & Dombrowski, Y. (2019) · Cells · doi:10.3390/cells8111424 · Cited by 625
“This results in demyelination, which is characterised by destruction of the myelin sheath and death of oligodendrocytes [194] leaving axons denuded and vulnerable to neurodegeneration [1].”
BackgroundOligodendroglial Energy Metabolism and (re)Myelination
Tepavčević, V. (2021) · Life · doi:10.3390/life11030238 · Cited by 57
“Importantly, alterations of oligodendrocytes and CNS myelin are a feature of several central nervous system pathologies including leukodystrophies (genetic disorders that lead to dys/de-myelination), spinal cord injury (in which myelin loss around spared axons significantly contributes to permanent damage), multiple s…”
BackgroundGroh, J., Abdelwahab, T., Kattimani, Y., Hörner, M., Loserth, S., Gudi, V., Adalbert, R., Imdahl, F., Saliba, A.-E., Coleman, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42570-2 · Cited by 39
“However, these evolutionary bene fi ts are associated with an increased vulnerability of white matter to various pathogenic processes including disease-and aging-related immune reactions 3 – 8 .”
BackgroundThe Median Eminence, A New Oligodendrogenic Niche in the Adult Mouse Brain
Zilkha-Falb, R., Kaushansky, N., & Ben-Nun, A. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.04.005 · Cited by 19
Jagielska, A., Radzwill, K., Espinosa-Hoyos, D., Yang, M., Kowsari, K., Farley, J. E., Giera, S., Byrne, A., Sheng, G., Fang, N. X., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-44675-6 · Cited by 10
Metadata
- Authors
- Duncan, I. D., & Radcliff, A. B.
- Venue
- Experimental Neurology
- Publisher
- Elsevier BV
- Published
- 2016-09
- Volume
- 283
- Issue
- Pt B
- Pages
- 452-475
- ISSN
- 0014-4886 (ISSN-L)
- OpenAlex
- W2324568579
- Cited by
- 141
- References
- 45
- FWCI
- 6.78
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inherited and acquired disorders of myelin: The underlying myelin pathology. https://app.cochat.ai/papers/10.1016/j.expneurol.2016.04.002
- The paper
- Duncan, I. D., & Radcliff, A. B. (2016). Inherited and acquired disorders of myelin: The underlying myelin pathology. Experimental Neurology. https://doi.org/10.1016/j.expneurol.2016.04.002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.